Healthcare Industry News: microfluidics
News Release - January 10, 2007
Amphora Discovery Corporation Appoints New PresidentRESEARCH TRIANGLE PARK, N.C., Jan. 10 (HSMN NewsFeed) -- Amphora Discovery Corporation, Inc. announced today that William P. Janzen has been named President and Chief Operating Officer. Prior to his promotion, Mr. Janzen served as Amphora's Vice President of Operations and Chief Technology Officer and led the transformation of the company's proprietary high performance drug discovery platform into a value-added contract services organization. Prior to co-founding Amphora, Mr. Janzen spent eighteen years in pharmaceutical research and development at Eli Lilly & Company and at Sphinx Pharmaceuticals.
"Improving the pace and yield of drug discovery and development is critical to the pharmaceutical and biotechnology companies. The need to abbreviate the time and reduce the cost of the discovery phase while identifying and advancing potent, selective leads into development has never been greater," stated Amphora's Chairman, Peter Savas. "Nimble, efficient independent service providers are playing an increasingly important role in improving R&D productivity. That in turn is creating a market for contract services that is expected to grow to over $1 billion dollars by 2010. Bill and his team have done an excellent job of positioning Amphora to provide best-in- class, highly cost effective drug discovery services."
Mr. Janzen stated, "Our mission is simple: We help our customers significantly improve R&D productivity. Amphora has a portfolio of services and capabilities that we perform with absolute attention to detail. Our guiding principle is to consistently deliver excellence in all that we do thereby providing our customers with data that always meets or exceeds their expectations. The Amphora platform is precise, flexible, industrialized and scalable so whether we are performing selectivity profiling, high throughput screening or specialized lead discovery services, we know our customers are satisfied with our work."
For further information, please contact:
President, Chief Operating Officer
Amphora Discovery Corporation
About Amphora Discovery Corp.
Amphora Discovery Corporation is a leading biotechnology company, with two dedicated business units. The Amphora Pharma Business Unit is focused on development and out-licensing of the company's broad selection of high-value lead candidates. The Amphora Discovery Business Unit is a leading provider of integrated contract services for the pharmaceutical industry, employing cutting-edge chemogenomic, systems biology and microfluidics technologies to deliver innovative and targeted lead generation and lead optimization solutions. Amphora is privately owned, with its headquartered in Research Triangle Park, North Carolina and can be found on the web at www.amphoracorp.com.
For further information on Amphora Discovery Corp. please contact:
Vice President, Business Development
Amphora Discovery Corporation, Inc.
Source: Amphora Discovery Corporation
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.